ATAP Inclusion/Exclusion and List of Study Sites
Posted on: December 07, 2009
This information was complied from the information provided on clinicaltrials.gov.
To read, please download file by clicking here.
The Official Website of the Acid Maltase Deficiency Association
It is difficult to say what is impossible for the dreams of yesterday are the hopes of today and the reality of tomorrow. - Robert H. Goddard
Get Involved
Your generous contribution will go a long way into improving the quality of life of Pompe Disease Patients worldwide. Donations go towards Pompe Disease Research.
Recently Added Items
- microRNAs as biomarkers in Pompe disease was posted in Publications, last July 12, 2018
- Severe Cardiac Involvement Is Rare in Patients with Late-Onset Pompe Disease and the Common c.-32-13 was posted in Publications, last July 01, 2018
- Press Release from Erasmus Medical Center: Making Muscle from Skin was posted in News, last June 26, 2018
- Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Base was posted in Publications, last June 01, 2018
- Enzyme replacement therapy reduces the risk for wheelchair dependency in adult Pompe patients was posted in Publications, last May 22, 2018
Disclaimer: The AMDA does not endorse any of the products, medications, treatments or information reported herein. The website and its contents is intended for informational purposes, only. We strongly advise that you discuss all medications, treatments, and/or products with your physician.
© 2011 Acid Maltase Deficiency Association
Address: AMDA PO Box 700248
San Antonio, Texas 78270 USA